Protein Tyrosine Kinase Inhibitors as Therapeutic Agents

  • Chapter
  • First Online:
Bioorganic Chemistry of Biological Signal Transduction

Part of the book series: Topics in Current Chemistry ((TOPCURRCHEM,volume 211))

Abstract

Protein tyrosine kinases (PTKs) play a key role in cell signaling and regulate biological processes such as proliferation, differentiation, and apoptosis. The malfunctioning of these proteins is the root of many diseases. Over 60% of all oncoproteins and proto-oncoproteins, which play a key role in cancers, are PTKs. Malfunctioning of PTKs is also the hallmark of other diseases such as psoriasis, Papilloma, Atherosclerosis, pulmonary fibrosis and more. It is therefore logical to target these proteins for drug design aiming at selective and nontoxic drugs. Since the second half of the 1980s we have pioneered and continued to generate tyrosine phosphorylation inhibitors (tyrphostins) as agents against diseases such as cancers, leukemias, lymphomas, psoriasis, restenosis, angiogenesis, and more. Currently, there are already a few tyrphostins in clinical trials. We argue that it is likely that the most effective tyrphostins in the future will be those which target the substrate binding domain of the PTK and not the ATP sub-domain. It is highly likely that tyrphostins against the key PTKs that play a pivotal role in diseases will become an important component in human therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

eBook
USD 9.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

9 References

  1. Levitzki A (1994) Eur J Biochem 226:1

    Article  CAS  Google Scholar 

  2. Levitzki A (1996) Curr Opin Cell Biol 3:239

    Article  Google Scholar 

  3. Levitzki A, Gazit A (1995) Science 267:1782

    Article  CAS  Google Scholar 

  4. Ben-Bassat H, Rosenbaum-Mitrani S, Hartzstark Z, Shlomai Z, Kleinberger-Doron N, Gazit A, Plowman G, Levitzki R, Tsvieli R, Levitzki A (1997) Cancer Res 57:3741

    CAS  Google Scholar 

  5. Ben-Bassat H, Vardi DV, Gazit A, Klaud SN, Chaouat M, Hartzstark Z, Levitzki A (1995) Experimental Dermatology 4:82

    Article  CAS  Google Scholar 

  6. Dvir A, Milner Y, Chomsky O, Gilon C, Gazit A, Levitzki A (1991) J Cell Biol 113:857

    Article  CAS  Google Scholar 

  7. Powell TJ, Ben-Bassat H, Klein B, Chen H, Shenoy N, McCollough J, Narog B, Gazit A, Harstark Z, Chaouat M, Tang C, McMahon J, Shawver L, Levitzki A (2000) Br J Dermatol 14: 802–810 (1999)

    Google Scholar 

  8. Anafi M, Gazit A, Gilon C, Ben-Neriah Y, Levitzki A (1992) J Biol Chem 267:4518

    CAS  Google Scholar 

  9. Carroll M, Tomasson M, Barker G, Golub T, Gillialand D (1996) Proc Natl Acad Sci USA 10: 14845

    Article  Google Scholar 

  10. Meydan N, Grunberger T, Dadi H, Shahar M, Arpaia E, Lapidot Z, Leader S, Freedman M, Cohen A, Gazit A (1996) Nature 379:645

    Article  CAS  Google Scholar 

  11. Yoneda T, Lyall RMAM, Pearsons PE, Spada AP, Levitzki A, Zilberstein A, Mundy GR (1991) Cancer Res 51:4430

    CAS  Google Scholar 

  12. Tsai CM, Levitzki A, Wu L-H, Chang K-T, Cheng C-C, Gazit A, Pemg R-P (1996) Cancer Res 56:1068

    CAS  Google Scholar 

  13. Nagane M, Levitzki A, Cavenee WK, Su Huang H-J (1998) Proc Natl Acad Sci USA 95:5724

    Article  CAS  Google Scholar 

  14. Yaish P, Gazit A, Gilon C, Levitzki A (1988) Science 242:933

    Article  CAS  Google Scholar 

  15. Levitzki A (1992) FASEB J 6:3275

    CAS  Google Scholar 

  16. Groundwater PW, Solomons KRH, Drewe JA, Munawar MA (1996) Progr Med Chem 33:233

    Article  CAS  Google Scholar 

  17. Posner I, Engel M, Levitzki A (1992) J Biol Chem 267:20638

    CAS  Google Scholar 

  18. Posner I, Engel M, Gazit A, Levitzki A (1994) Mol Pharmacol 45:673

    CAS  Google Scholar 

  19. Kovalenko M, Gazit A, Bohmer A, Rorsman C, Ronnstrand L, Heldin C, Waltenberger JFD, Bohmer F, Levitzki A (1994) Cancer Res 54:6106

    CAS  Google Scholar 

  20. Gazit A, App H, McMahon G, Chen J, Levitzki A, Bohmer FD (1996) J Med Chem 39: 2170

    Article  CAS  Google Scholar 

  21. Ward WHJ, Cook PN, Slater AM, Davies DH, Holdgate GA, Gree LR (1994) Biochem Pharmacol 48:639

    Article  Google Scholar 

  22. Kovalenko M, Romstrand L, Heldin C-H, Loubochenko M, Gazit A, Levitzki A, Bohmer FD (1997) Biochemistry 36:6260

    Article  CAS  Google Scholar 

  23. Levitzki A, Bohmer FD (1998) Anticancer Drug Des 13:731–734

    CAS  Google Scholar 

  24. Mohammadi M, McMahon G, Sun L, Tang C, Hirth P, Yeh BK, Hubbard SR, Schlessinger J (1997) Science 276:955

    Article  CAS  Google Scholar 

  25. Mohammadi M, Froum S, Hamby JM, Schroeder MC, Panek RL, Lu GH, Eliseenkova AV, Green D, Schlessinger J, Hubbard S (1998) EMBO J 1720:5896

    Article  Google Scholar 

  26. Schindler T, Sicheri F, Pico A, Gazit A, Levitzki A, Kuriyan J (1999) Mol Cell 3:639

    Article  CAS  Google Scholar 

  27. Zhu X, Kim JL, Newcomb JR, Rose PE, Stover DR, Toledo LM, Zhao H, Morgenstern KA (1999) Structure Fold 7:65,125

    Google Scholar 

  28. Levitzki A (1996) Anti-Cancer Drug Design 11:75

    Google Scholar 

  29. Osherov N, Levitzki A (1994) Eur J Biochem 225:1047

    Article  CAS  Google Scholar 

  30. Hubbard SR, Wei L, Ellis L, Hendrikson W (1997) Nature 372:746

    Article  Google Scholar 

  31. Hubbard SR (1997) EMBO J 16:5572

    Article  CAS  Google Scholar 

  32. Blum G, Gazit A, Levitzki A (1998) (submitted)

    Google Scholar 

  33. Parrizas M, LeRoith D (1997) Endocrinology 138:1355

    Article  CAS  Google Scholar 

  34. Lopez-Talavera JC, Levitzki A, Martinez A, Gazit A, Esteban E, Guardian J (1997) J Clin Invest 100:664

    Article  CAS  Google Scholar 

  35. Sevransky JE, Shaked G, Novogrodsky A, Levitzki A, Gazit A, Hoffman Z, Quezado BD (1997) J Clin Invest 99:1966

    Article  CAS  Google Scholar 

  36. Vanichkin A, Palya M, Gazit A, Levitzki A, Novogrodsky A (1996) J Infect Dis 173:927

    CAS  Google Scholar 

  37. Novogrodsky A, Vanichkin M, Patya A, Gazit N, Osherov N, Levitzki A (1994) Science 264:1319

    Article  CAS  Google Scholar 

  38. Waltenberger J, Uecker A, Kroll J, Frank H, Mayr U, Bjorge JD, Fujita D, Gazit A, Hombach V, Levitzki A, Bohmer FD (1999) Circ Res 85:12

    CAS  Google Scholar 

  39. Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, Zimmermann J, Lydon NB (1996) Nat Med 2:561

    Article  CAS  Google Scholar 

  40. Buchdunger E, Zimmermann J, Mett H, Meyer T, Muller M, Druker BJ, Lydon NB (1996) Cancer Res 56:100

    CAS  Google Scholar 

  41. Buchdunger E, Mett H, Trinks U, Regenass U, Muller M, Meyer T, Beilstein P, Wirz B, Schneider P, Traxler P (1995) Clin Cancer Res 1:813

    CAS  Google Scholar 

  42. Buchdunger E, Zimmermann J, Mett H, Meyer T, Muller M, Regenass U, Lydon N (1995) Proc Natl Acad Sci USA 92:2558

    Article  CAS  Google Scholar 

  43. Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning, S, Zimmermann J, Lydon NB (1996) Nature Med 2:561

    Article  CAS  Google Scholar 

  44. Kaur G, Gazit A, Levitzki A, Stowe E, Cooney DA, Sausville EA (1994) Anti-Cancer Drugs 5:213

    Article  CAS  Google Scholar 

  45. Carlo-Stella C, Regazzi E, Sammarelli G, Colla S, Garau D, Gazit A, Savoldo B, Cilloni D, Tabilio A, Levitzki A, Rizzoli V (1999) Blood 93:3973

    CAS  Google Scholar 

  46. Banai S, Wolf Y, Golomb G, Pearle A, Waltenberger J, Fishtein I, Schneider A, Gazit A, Perez L, Huber R, Lazarovichi G, Levitzki A, Gertz SD (1998) Circulation 19:1960

    Google Scholar 

  47. Fishben I, Waltenberger J, Banai S, Rabinovich L, Chorny M, Levitzki A, Gazit A, Huber R, Gertz DS, Golomb G (2000) (in press)

    Google Scholar 

  48. Fry DW, Kraker AJ, McMichael A, Ambroso LA, Nelson JM, Leopold WR, Connors RW, Bridges AJ (1994) Science 265:1093

    Article  CAS  Google Scholar 

  49. Gazit A, Chen J, App H, McMahon G, Hirth P, Chen I, Levitzki A (1996) Biorg Med Chem 8:1203

    Article  Google Scholar 

  50. Bridges A J, Zhou H, Cody DR, Rewcastle GW, McMichael A, Showalter HDH, Fry DW, Kraker AJ, Denny WA (1996) J Med Chem 39:267

    Article  CAS  Google Scholar 

  51. Traxler PM, Furet P, Mett H, Buchdunger E, Meyer T, Lydon N (1996) J Med Chem 39:2285

    Article  CAS  Google Scholar 

  52. Rewcastle GW, Palmer BD, Bridges AJ, Showalter HD, Sun L, Nelson J, McMichael A, Kraker AJ, Fry DW, Denny WA (1996) J Med Chem 39:918

    Article  Google Scholar 

  53. Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fernandez-Luna JL, Nunez G, Dalton WS, Jove R (1999) Immunity 10:105

    Article  CAS  Google Scholar 

  54. Burdeyla L, Carlett-Falcone R, Levitzki A, Coppola D, Dalton WD, Jove R, Yu H (2000) Cancer Res., in press

    Google Scholar 

  55. Bilder G, Wentz T, Leadley R, Amin D, Byan L, O’Conner B, Needle S, Galczenski H, Bostwick J, Kasiewski C, Myers M, Spada A, Merkel L, Ly C, Persons P, Page K, Perrone M, Dunwiddie C (1999) Circulation 99:3292–3299

    CAS  Google Scholar 

  56. Ross R, Glomset JA (1976) N Ing J Med 295:369

    Article  CAS  Google Scholar 

  57. Ross R (1986) N Ing J Med 314:488

    Article  CAS  Google Scholar 

  58. Sharfe N, Dadi HK, Roifman CM (1995) Blood 86:2077

    CAS  Google Scholar 

  59. Lydon NB, Mett H, Mueller M, Becker M, Cozens RM, Stover D, Daniels D, Traxler P, Buchdunger E (1999) Int J Cancer 81:669

    Article  CAS  Google Scholar 

  60. Brenner T, Poradosu E, Soffer D, Sicsic C, Gazit A, Levitzki A (1998) Exp Neurol 154:489

    Article  CAS  Google Scholar 

  61. Orlicek SL, Hanke JH, English BK (1999) Shock 12:350

    Article  CAS  Google Scholar 

  62. Han Y, Rogers N, Ransohoff RM (1999) Interferon Cytokine Res 7:731

    Article  Google Scholar 

  63. Fuortes M, Melchior M, Han H, Lyon GJ, Nathan C (1999) Clin Invest 3:327

    Google Scholar 

  64. Yan SR, Novak MJ (1999) Inflammation 2:167

    Article  Google Scholar 

  65. Hanna AN, Chan EY, Xu J, Stone JC, Brindley DN (1999) J Biol Chem 274:12,722

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Levitzki, A. (2000). Protein Tyrosine Kinase Inhibitors as Therapeutic Agents. In: Waldmann, H. (eds) Bioorganic Chemistry of Biological Signal Transduction. Topics in Current Chemistry, vol 211. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-45035-1_1

Download citation

  • DOI: https://doi.org/10.1007/3-540-45035-1_1

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-67746-8

  • Online ISBN: 978-3-540-45035-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Navigation